News
StockStory.org on MSN2mon
Why Incyte (INCY) Stock Is NosedivingShares of biopharmaceutical company Incyte Corporation (NASDAQ:INCY) fell 15.2% in the pre-market session after the company ...
StockStory.org on MSN3mon
Earnings To Watch: Incyte (INCY) Reports Q4 Results TomorrowBiopharmaceutical company Incyte Corporation (NASDAQ:INCY) will be reporting earnings tomorrow before the bell. Here’s what ...
Biopharmaceutical company Incyte Corporation (NASDAQ:INCY) reported Q1 CY2025 results exceeding the market’s revenue expectations , with sales up 19.5% year on year to $1.05 billion. Its non ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback